PTN and Cognitive impairment: For example, CSF levels of a pleiotrophin peptide (amino acids 151 to 166) were found to progressively increase with severity of cognitive impairment in individuals with AD, mild cognitive impairment, and subjective cognitive decline, but not in healthy controls with no evidence of cognitive impairment or individuals with PD or progressive supranuclear palsy [131].